A Study of Samuraciclib and Elacestrant in Participants With Metastatic or Locally Advanced HR+/HER2-negative Breast Cancer
Clinical trial NCT05963997 · COMPLETED
Trial details
- NCT number
- NCT05963997
- Sponsor
- Carrick Therapeutics Limited
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-09
- Primary completion
- 2026-03-06
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.